Paul Nghiem, MD, PhD, and the Nghiem Lab have championed innovations in MCC treatment, delivering new treatment options, ...

Ac-SSO110 has now received FDA orphan drug designation and investigational new drug application clearance for the treatment ...

Discover how AI-powered DeepMerkel improves survival predictions for Merkel cell carcinoma, offering personalized treatment insights for better outcomes.

Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.

An enhanced model that integrates non-AJCC clinical features provides clinicians with a more accurate tool for identifying high-risk patients with MCC.

HURA READ THE FULL HURA RESEARCH REPORT We are initiating coverage of TuHURA Biosciences, Inc. (NASDAQ:HURA) with a valuation ...

In what is being called a major leap forward for cancer care, researchers have developed an artificial intelligence (AI) ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune cells in ...

The following is a summary of “Skin cancer risk in over 200.000 patients with haematologic malignancies in 30 years; a ...